$99.4 Million is the total value of Sunesis Advisors, LLC's 31 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DCPH | DECIPHERA PHARMACEUTICALS IN | $3,965,000 | -33.9% | 96,299 | 0.0% | 3.99% | -26.9% | |
| VEA | VANGUARD TAX MANAGED INTL FDftse dev mkt etf | $3,781,000 | -24.3% | 113,404 | 0.0% | 3.80% | -16.4% | |
| BIV | VANGUARD BD INDEX FD INCintermed term | $3,055,000 | +2.4% | 34,204 | 0.0% | 3.07% | +13.2% | |
| MUNI | PIMCO ETF TRinter mun bd act | $2,284,000 | -1.2% | 41,872 | 0.0% | 2.30% | +9.2% | |
| TIP | ISHARES TRtips bd etf | $2,039,000 | +1.2% | 17,288 | 0.0% | 2.05% | +11.8% | |
| MUB | ISHARES TRnational mun etf | $1,950,000 | -0.8% | 17,257 | 0.0% | 1.96% | +9.6% | |
| VGSH | VANGUARD SCOTTSDALE FDSshort term treas | $1,606,000 | +2.5% | 25,754 | 0.0% | 1.62% | +13.3% | |
| IAU | ISHARES GOLD TRUSTishares | $1,574,000 | +4.0% | 104,418 | 0.0% | 1.58% | +14.9% | |
| SCHE | SCHWAB STRATEGIC TRemrg mkteq etf | $1,349,000 | -24.4% | 65,224 | 0.0% | 1.36% | -16.5% | |
| IUSB | ISHARES TRcore total usd | $756,000 | +0.7% | 14,403 | 0.0% | 0.76% | +11.1% | |
| LMRK | LANDMARK INFRASTRUCTURE LP | $653,000 | -35.6% | 61,815 | 0.0% | 0.66% | -28.8% | |
| BK | BANK NEW YORK MELLON CORP | $621,000 | -33.1% | 18,436 | 0.0% | 0.62% | -26.0% | |
| VTV | VANGUARD INDEX FDSvalue etf | $395,000 | -25.8% | 4,436 | 0.0% | 0.40% | -18.0% | |
| VO | VANGUARD INDEX FDSmid cap etf | $267,000 | -26.2% | 2,030 | 0.0% | 0.27% | -18.5% | |
| PAA | PLAINS ALL AMERN PIPELINE Lunit ltd partn | $141,000 | -71.2% | 26,669 | 0.0% | 0.14% | -68.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-04-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 21 | Q3 2023 | 47.2% |
| ISHARES TR | 21 | Q3 2023 | 14.4% |
| VANGUARD STAR FDS | 21 | Q3 2023 | 7.3% |
| ISHARES TR | 21 | Q3 2023 | 5.8% |
| DECIPHERA PHARMACEUTICALS IN | 21 | Q3 2023 | 5.5% |
| VANGUARD SCOTTSDALE FDS | 21 | Q3 2023 | 3.6% |
| PIMCO ETF TR | 21 | Q3 2023 | 3.2% |
| ISHARES TR | 21 | Q3 2023 | 2.3% |
| VANGUARD INTL EQUITY INDEX F | 21 | Q3 2023 | 2.3% |
| VANGUARD INTL EQUITY INDEX F | 21 | Q3 2023 | 2.3% |
View Sunesis Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-01-19 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-02-02 |
| 13F-HR | 2022-11-02 |
| 13F-HR | 2022-07-27 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-10-27 |
View Sunesis Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.